Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesHome Health & HospiceBCBS Vermont Home Infusion Coverage Update | OpenP…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield of VermontPolicy 8.03.VT201

    Home Infusion Therapy Corporate Medical Policy

    Customize your policy alerts

    Sign up for bcbsvermont Policy 8.03.VT201 alerts

    Get alerted when Policy 8.03.VT201 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical necessity for home infusion therapy delivered through intravenous solutions or injectable medications for Blue Cross Blue Shield of Vermont members, subject to the member’s contract and benefit plan.

    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyHome Infusion Therapy Corporate Medical Policy
    Policy CodePolicy 8.03.VT201
    Change TypeNo material clinical or coverage change
    Effective DateMar 1, 2026
    Last ReviewSep 1, 2025
    Next Review DateSep 1, 2026
    Key ActionConsult the Blue Cross VT Drug Prior Approval Listing to determine whether the prescribed drug requires prior approval.
    SourceLink
    POLICY UPDATE CHANGES

    The September 2025 review removed the coding table from the policy while stating that there was no change to the policy statement.

    6Medical necessity criteria
    IV, SC, IMAdministration routes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    FDA approvedDrug approval
    Network/preferredProvider status
    Not medically necessaryCriteria not met
    Contract controlsBenefit precedence

    Home Infusion Therapy Coverage Criteria

    Home infusion therapy medical necessity

    Covered when ALL of the following are met:

    All required criteria

    • Drug approval: The prescription drug is FDA approved.FDA approved
    • Prescription authority: The therapy regimen is prescribed by a medical doctor (MD or DO), physician assistant (PA), or nurse practitioner (NP).MD, DO, PA, or NP
    • Home management: The therapy is managed in the home by a medical doctor (MD or DO), physician assistant (PA), nurse practitioner (NP), or registered nurse (RN).MD, DO, PA, NP, or RN
    • Safe home administration: The treatment can be safely administered in the home.
    • Treatment duration: The prescribed home infusion therapy regimen is for a period of time that does not exceed the standard of care for the condition being treated.Does not exceed the standard-of-care duration
    • Provider status: Services are provided by a network or preferred home infusion therapy provider.Network/preferred provider

    Home infusion therapy that does not meet the stated medical necessity criteria is not covered as medically necessary under this policy.

    Home infusion therapy is considered not medically necessary when it fails to satisfy any one of the required medical necessity criteria.

    Coding Reference and Historical Updates

    Historical coding updates and removals - not a current coding tableHCPCS
    A4220Code removed from the coding table in the 03/2018 policy update; no current descriptor provided.
    A4221Code removed from the coding table in the 03/2018 policy update; no current descriptor provided.
    B4164Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4168Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4172Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4176Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4178Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4180Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4185Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    B4189Code removed in the 08/2019 update and directed to the Corporate TPN Medical Policy; no current descriptor provided.
    1–10 of 30
    1/3

    Provider Requirements and Submission Guidance

    Prior Authorization

    Check drug-specific prior approval

    Certain drugs may require prior approval. Consult the Blue Cross VT Drug Prior Approval Listing to determine whether the prescribed drug requires approval.

    Note

    Verify plan-specific requirements

    Prior approval is not required under the general benefit determination guidance, but benefits remain subject to all terms, limitations, and conditions of the subscriber contract. Verify the member’s applicable contract and benefit plan requirements before providing the service.

    Documentation Required

    Support all medical necessity criteria

    Home Infusion Therapy Overview

    Infusion therapy administers medication through a needle or catheter, most commonly intravenously, when a condition cannot be effectively treated with oral medication. Home infusion may also be delivered by subcutaneous or intramuscular injection and may be used for treatments such as antibiotics, antifungals, antivirals, chemotherapy, hydration, pain management, parenteral nutrition, and specialty medications.

    Key Definition

    Infusion therapy
    Administration methodMedication is administered through a needle or catheter.
    Typical routeUsually administered intravenously.
    Other non-oral routesMay also be provided through intramuscular injections or epidural routes.
    Clinical usePrescribed when a patient’s condition cannot be treated effectively with oral medications.
    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyHome Infusion Therapy Corporate Medical Policy
    Policy CodePolicy 8.03.VT201
    Change TypeNo material clinical or coverage change
    Effective DateMar 1, 2026
    Last ReviewSep 1, 2025
    Next Review DateSep 1, 2026
    Key ActionConsult the Blue Cross VT Drug Prior Approval Listing to determine whether the prescribed drug requires prior approval.
    SourceLink
    On This Page
    Home Infusion Therapy Coverage CriteriaCoding Reference and Historical UpdatesProvider Requirements and Submission GuidanceHome Infusion Therapy OverviewKey Definition

    Submit documentation establishing each applicable medical necessity requirement, including the prescribed drug’s FDA approval, prescribing and managing clinician credentials, safety of home administration, treatment duration, and network or preferred provider status.

    • FDA approval of the prescribed drug
    • Prescribing and managing clinician credentials
    • Safe administration in the home
    • Treatment duration that does not exceed the standard of care
    • Network or preferred home infusion therapy provider status
    Documentation Required

    Submit complete requests

    Incomplete authorization requests may result in a delay of the decision pending submission of missing information. Include the information needed to demonstrate compliance with the policy guidelines.

    Denial Risk

    Failure to meet medical necessity criteria

    Home infusion therapy that does not meet the policy’s medical necessity criteria is considered not medically necessary.

    Denial Risk

    Nonpreferred provider or audit noncompliance

    Services must be provided by a network or preferred home infusion therapy provider. Blue Cross VT may audit any provider or facility for compliance and may recoup all noncompliant payments identified through an audit.

    • Use a network or preferred home infusion therapy provider.
    • Maintain compliance with the medical policy guidelines.
    • Noncompliant payments may be recouped after audit.